• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Don't Dread a Market Correction, Think Opportunistically Instead

Go on the offensive rather than turn defensive and miss the opportunities that are developing.
By JAMES "REV SHARK" DEPORRE
Sep 08, 2018 | 10:00 AM EDT
Stocks quotes in this article: ZGNX, AMRS

Market corrections are too often feared by market players rather than embraced. For many investors, the attitude is that the only good market is one that is going straight up every day. That is a nice, though unrealistic, goal if you are long-term passive investor. However, if you trade even a little bit, it is the downside action that creates the big opportunities.

Rather than fear and dread market weakness, it should be viewed as an opportunity. The problem is that optimism tends to erode when there is a poor market and we are dealing with losses in individual stocks. Rather than think offensively, we turn defensive and tend to forget about the opportunities that are developing.

The best way to develop an opportunistic mindset is not to use up your mental and emotional energy dealing with negatives. You need a solid plan for the positions you are holding and then to act on it. Too often, traders aren't sure what to do when there is a pullback and that uses up all their energy.

If you can set aside the negative emotions created by losses, it then becomes much easier to start thinking in terms of opportunity.

The first step in taking advantage of opportunities created by weak markets is to have a shopping list. Many stocks are sold without regard to fundamentals or future prospects in a weak market and that is where we want to look. What stocks are most likely to bounce back quickly after a market selloff subsides?

I focus on stocks that not only have good fundamentals but also are likely to have a positive catalyst in the near future. I don't want to buy just because it is perceived as cheap due to where it is relative to recent action but because there is likely to be some sort of news that will interest investors.

In many cases it isn't even important to hold for the actual news. All that there needs to be is some anticipation of a positive outcome. A stock with good fundamentals and the potential for good news is going to attract buyers at some point. That is the action we want to exploit.

A good example of the sort of stock I'm looking at is Zogenix Inc. (ZGNX) . Back in mid-July the company announced positive news for a drug that treats Dravet syndrome, which is a form of epilepsy. The stock spiked to $62.75 but has been in a downtrend since then.

Zogenix caused some of the pressure by doing a secondary offering at $52, which was not timed very well or even necessary. When that pricing failed to hold another round of selling hit and took the stock down to $45 on Thursday.

On Friday morning an analyst at B. Riley FBR placed a target of $116 on Zogenix and stated that it believes its drug has blockbuster potential. The company is likely to have more data before the end of the year, which is the potential catalyst that many market players will be anticipating.

The chart of ZGNX is quite unattractive right now. It is below key support levels and moving averages, but there does seem to be support at $45.

My game plan is to slowly average in to the sock. By slowly I mean over the course of weeks. I'll look to buy on dips and then would ramp up my buying when the stock moves back over the $50 level and develops some positive momentum again.

If you look at the chart of Zogenix right now the easy conclusion is that there is something wrong with the stock. Obviously someone wanted out and they weren't too concerned about getting a good price. There may be an unknown negative so you have to still have a stop-loss point in mind. I'd probably cut the position some if it closed under $45.

A lot will depend on overall market action, too. The stock sold off in large part due to weakness in biotechnology in general. It will bounce with the sector as well.

There are other stocks on my shopping list that aren't in a downtrend. For example, Amyris Inc. (AMRS) had a strong move following recent news that it is unveiling a natural, no-calorie sugar substitute made from sugar cane. However, it then would decline four days in a row in the weak market. There is some support around $8, which looks like a good entry in anticipation of the actual news in the next couple months.

Weak markets are what create the best opportunities. The key to taking advantage is to have the right mindset, finding the right stocks and then developing a plan for trading them. The worse the market action, the better the opportunities, so rather than dread downside we should be welcoming it.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long ZGNX and AMRS.

TAGS: Investing

More from Investing

Emotions Run High as Indexes Slip

James "Rev Shark" DePorre
Jan 27, 2021 4:44 PM EST

I've raised a bit of cash, but it's still unclear what will emerge from here.

'Mortal Kombat' on the Market

Peter Tchir
Jan 27, 2021 3:54 PM EST

Let's pick apart the wild action in individual stocks -- especially GameStop -- and see what to expect going forward.

Butterflies Are Free: This GameStop Options Play Is Hardly Ever Seen

Timothy Collins
Jan 27, 2021 3:01 PM EST

I'll take a 66% risk-free rate of return in six months anytime.

Walgreens Boots Alliance Rallies Ahead of Earnings

Bruce Kamich
Jan 27, 2021 2:45 PM EST

Has WBA rallied too much?

Apple Earnings Land After Close -- Here's What the Charts Say

Bruce Kamich
Jan 27, 2021 2:09 PM EST

This is what I see going into the release of AAPL's quarterly report.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:48 AM EST STEPHEN GUILFOYLE

    Cashing in Some More Chips at Stocks Under $10

    We're trimming a position for a big gain today.
  • 08:34 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 1/27/2021

    The "correction" can be coming sooner than we thou...
  • 09:35 AM EST CHRIS VERSACE

    Another Big Winner for Stocks Under $10

    We're ringing the register Tuesday morning.
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login